Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)

NCT00322621 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathies

Interventions

DRUG: Duloxetine

Sponsor

Eli Lilly and Company

Collaborators

[object Object]